![]() |
Life After Stroke: Personal Perspectives
|
Botulinum is a bacterium (Clostridium botulinum) that produces seven different toxins that can cause botulism and is also medically used to block muscle contractions.
Botulinum toxin (Botox) injection is used in conditions of excessive and inappropriate muscle contraction, hyperhidiosis (excess sweating) in armpits and palms, spasticity (persistent states of muscle contraction), sphincter contraction, eye-movement disorders, tics and tremors, and cosmetically to treat facial lines and wrinkles.
Botox has also been explored in the treatment of chronic muscle tension and migraine headaches. The relief is likely due to the decrease in localized muscle spasms, as no direct effect of Botox on the sensory nerves has been established.
Botulinum toxin is produced from the bacterium that causes food poisoning in humans. High doses of the toxin can be fatal; however, doses administered therapeutically are so small that harmful effects are uncommon.
The number of potential applications for botulinum toxin extends to every muscle group. The first therapeutic use of Botox was in the treatment of strabismus (eyes are unable to direct towards the same object) and since then it has been used to treat a variety of involuntary muscle contractions or disorders. Its cosmetic use is the result of treatment for facial spasms where smoothing of facial lines was reported by patients. In general, 90% of injections for facial spasms are resolved satisfactorily.
Toxin type A has a duration of effect that lasts approximately three months and is the therapeutic agent of choice for most conditions.
The dosage of Botox must be monitored and adjusted, with multiple injections showing a lower incidence of complications versus administration by one larger dose.
In over 30 years of therapeutic use in humans, botulinum toxin has proven to be remarkably safe. Difficulties
Additional side effects may include excessive muscle weakness at the injection site or adjacent muscles. These effects typically resolve quickly. Occasionally, patients report flu-like symptoms but they are usually self-limited.
A certain percentage of patients may also experience resistance to the toxin. The presence of circulating anti-bodies to the toxin is presumed to be the primary reason for resistance to Botox injections. Patients who have little reaction to Botox 'A' may benefit from injections using one of the other six serotypes. Using the smallest effective dose limits the likelihood of immunoresistance in unresponsive patients.
|
|
Author Info: Bonny McClain DC, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Medicine, 2002 |